NASDAQ:MLAB Mesa Laboratories (MLAB) Stock Price, News & Analysis $102.16 +4.01 (+4.09%) Closing price 06/26/2026 03:59 PM EasternExtended Trading$102.12 -0.03 (-0.03%) As of 06/26/2026 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Mesa Laboratories Stock (NASDAQ:MLAB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Mesa Laboratories alerts:Sign Up Key Stats Today's Range$96.28▼$103.4350-Day Range$90.80▼$109.1352-Week Range$55.45▼$113.99Volume257,312 shsAverage Volume236,841 shsMarket Capitalization$563.92 millionP/E Ratio85.13Dividend Yield0.63%Price Target$94.00Consensus RatingReduce Company Overview Mesa Laboratories, Inc. (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes. The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications. Mesa Laboratories also offers calibration standards, software platforms and technical support services that enable clients to maintain accurate instrument performance and fulfill industry-specific quality assurance requirements. Since its founding in 1968, Mesa Laboratories has expanded through a combination of in-house research and development and strategic acquisitions to broaden its instrumentation offerings and geographic reach. The company maintains manufacturing and service facilities across North America, Europe and the Asia-Pacific region, leveraging a global distribution network to deliver products and support to customers in more than 100 countries.AI Generated. May Contain Errors. Read More Mesa Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScoreMLAB MarketRank™: Mesa Laboratories scored higher than 23% of companies evaluated by MarketBeat, and ranked 767th out of 852 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingMesa Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.Downside RiskMesa Laboratories has a consensus price target of $94.00, representing about 8.0% downside from its current price of $102.16.Amount of Analyst CoverageMesa Laboratories has only been the subject of 1 research reports in the past 90 days.Read more about Mesa Laboratories' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Mesa Laboratories is 85.13, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 45.97.Price to Earnings Ratio vs. SectorThe P/E ratio of Mesa Laboratories is 85.13, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.13.Price to Book Value per Share RatioMesa Laboratories has a P/B Ratio of 3.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Mesa Laboratories' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.55% of the float of Mesa Laboratories has been sold short.Short Interest Ratio / Days to CoverMesa Laboratories has a short interest ratio ("days to cover") of 0.89, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mesa Laboratories has recently decreased by 14.52%, indicating that investor sentiment is improving significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldMesa Laboratories has a dividend yield of 0.62%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthMesa Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Mesa Laboratories is 53.33%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Mesa Laboratories' dividend. News and Social Media1.2 / 5News Sentiment-0.07 News SentimentMesa Laboratories has a news sentiment score of -0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Mesa Laboratories this week, compared to 1 article on an average week. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $770,122.00 in company stock.Percentage Held by Insiders4.90% of the stock of Mesa Laboratories is held by insiders.Percentage Held by Institutions90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Mesa Laboratories' insider trading history. Receive MLAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MLAB Stock News HeadlinesJohn Sakys Sells 2,827 Shares of Mesa Laboratories (NASDAQ:MLAB) StockJune 25 at 4:39 AM | americanbankingnews.comInsider Selling: Mesa Laboratories (NASDAQ:MLAB) CAO Sells $39,559.00 in StockJune 24, 2026 | insidertrades.comA drilling crew just broke a record nobody expectedA drilling crew in Beaver County, Utah hit 15,765 feet of solid granite in 16 days - a job the Department of Energy projected would take 64. They reached DOE's 2035 performance targets twelve years early, cutting costs in half within 18 months. When Congress moved to cut solar and wind tax credits, this energy source kept its full credits through 2033. One company has been building in this space for sixty years, and a July 4th catalyst is now 12 days away.June 28 at 1:00 AM | Behind the Markets (Ad)Critical Contrast: Solana (NASDAQ:HSDT) & Mesa Laboratories (NASDAQ:MLAB)June 22, 2026 | americanbankingnews.comInsider Selling: Mesa Laboratories (NASDAQ:MLAB) CAO Sells 118 Shares of StockJune 18, 2026 | insidertrades.comMesa Laboratories Executives Quietly Unload Significant Stock HoldingsJune 17, 2026 | tipranks.comMesa Laboratories Promotes Lyndsey Crennen to Chief Accounting OfficerJune 15, 2026 | tipranks.comMesa Laboratories Confronts Rising Cyber Resilience Compliance Risks Under EU CRA Ahead of 2026 DeadlinesJune 4, 2026 | tipranks.comSee More Headlines MLAB Stock Analysis - Frequently Asked Questions How have MLAB shares performed this year? Mesa Laboratories' stock was trading at $78.50 at the beginning of 2026. Since then, MLAB stock has increased by 30.1% and is now trading at $102.16. How were Mesa Laboratories' earnings last quarter? Mesa Laboratories, Inc. (NASDAQ:MLAB) posted its earnings results on Wednesday, May, 27th. The medical instruments supplier reported $1.53 earnings per share for the quarter, missing the consensus estimate of $1.78 by $0.25. The medical instruments supplier earned $63.72 million during the quarter, compared to analysts' expectations of $65.21 million. Mesa Laboratories had a net margin of 2.69% and a trailing twelve-month return on equity of 20.96%. Who are Mesa Laboratories' major shareholders? Top institutional shareholders of Mesa Laboratories include Ranger Investment Management L.P. (3.68%), Dimensional Fund Advisors LP (2.26%), Roubaix Capital LLC (1.31%) and Janus Henderson Group PLC (1.26%). Insiders that own company stock include John Bradley Schmieder, Gary M Owens, John Sakys, Shiraz Shabanali Ladiwala, Brian David Archbold, R Tony Tripeny, Mark Christopher Capone and Lyndsey Elizabeth Crennen. View institutional ownership trends. How do I buy shares of Mesa Laboratories? Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Mesa Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings5/27/2026Record date for 6/15 Dividend5/29/2026Ex-Dividend for 6/15 Dividend5/29/2026Dividend Payable6/15/2026Today6/28/2026Next Earnings (Estimated)8/04/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 MLAB's financial health is in the Green zone, according to TradeSmith. MLAB has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryElectronic Equipment & Instruments Current SymbolNASDAQ:MLAB CIK724004 Webwww.mesalabs.com Phone(303) 987-8000Fax303-987-8989Employees680Year Founded1982Price Target and Rating Average Price Target for Mesa Laboratories$94.00 High Price Target$94.00 Low Price Target$94.00 Potential Upside/Downside-8.0%Consensus RatingReduce Rating Score (0-4)1.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$1.20 Trailing P/E Ratio85.13 Forward P/E RatioN/A P/E GrowthN/ANet Income$6.71 million Net Margins2.69% Pretax Margin4.82% Return on Equity20.96% Return on Assets8.78% Debt Debt-to-Equity Ratio0.78 Current Ratio1.72 Quick Ratio1.29 Sales & Book Value Annual Sales$249.13 million Price / Sales2.26 Cash Flow$11.74 per share Price / Cash Flow8.70 Book Value$33.71 per share Price / Book3.03Miscellaneous Outstanding Shares5,520,000Free Float5,254,000Market Cap$563.92 million OptionableNot Optionable Beta0.94 Social Links Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:MLAB) was last updated on 6/28/2026 by MarketBeat.com Staff. From Our PartnersSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredAre we ignoring the same signal Wall Street ignored in 1929?In 1929, a 20-something broker named Irving Weiss shorted the market before Black Monday and made a fortune. H...Weiss Ratings | SponsoredGold to $4,900—Here’s the Real PlayGold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...Investors Alley | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredFour winners over 400%. Here's #5CFA and CMT analyst Garrett Goggin called G2 Goldfields before it rose 1,023%, Reunion Gold before 538%, Highl...Golden Portfolio | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
